<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Maple Watch Health Data</title>
    <link>https://www.maple.watch/topics/health.html</link>
    <description>Hospitals, public health, emergency care, disease, and health services.</description>
    <language>en-ca</language>
    <item>
      <title>Canada Gazette Part I: Designation as fingerprint examiner [Royal Canadian Mounted Police]</title>
      <link>https://gazette.gc.ca/rp-pr/p1/2026/2026-05-23/html/notice-avis-eng.html#ne3</link>
      <guid isPermaLink="false">3c1fd74f38753bd5dec326eee546493dbe5928ce7117a065c8f8c5a6c86dca8d</guid>
      <description>Canada Gazette notice. Organization: Public Safety and Emergency Preparedness, Dept. of. Authority: Criminal Code.</description>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Canada Gazette Part I: Health-based air quality objectives for arsenic</title>
      <link>https://gazette.gc.ca/rp-pr/p1/2026/2026-05-23/html/notice-avis-eng.html#ne2</link>
      <guid isPermaLink="false">3540f8ac6afa257090879a8cf515cf7691edc79fb3db2ed1229ef6e80b87469a</guid>
      <description>Canada Gazette notice. Organization: Health, Dept. of. Authority: Canadian Environmental Protection Act, 1999.</description>
      <pubDate>Sat, 23 May 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Investigation into fatal officer-involved shooting in Winnipeg concluded</title>
      <link>https://open.alberta.ca/dataset/investigation-into-fatal-officer-involved-shooting-winnipeg-concluded</link>
      <guid isPermaLink="false">ec1024be94c0fc00adc0e433543ffb49b4eee39e5b640ea33192171c853cd764</guid>
      <description>The Alberta Serious Incident Response Team (ASIRT) has completed its investigation into a Winnipeg Police Service (WPS) officer-involved shooting and has released the acting executive director’s report.</description>
      <pubDate>Fri, 22 May 2026 21:21:52 +0000</pubDate>
    </item>
    <item>
      <title>Polycyclic Aromatic Hydrocarbons (PAHs) in Sediments, Mussels, and Clams along the Coast of British Columbia</title>
      <link>https://open.canada.ca/data/dataset/d79ae28e-606a-4984-8f9c-2f6e2bea7e0b</link>
      <guid isPermaLink="false">835482b504845ca28a190bd37f25f0e3a6c92a8002b83b8ea319ceed9328902b</guid>
      <description>Polycyclic aromatic hydrocarbons (PAHs) data for sediments and bivalve tissues along the coast of British Columbia (BC) have been compiled to support the Spill Response Team within Fisheries and Oceans Canada’s Integrated Marine Response Planning (IMRP) program. The data originate from Ocean Wise Conservation Association’s Pollution Tracker database and include sites funded by DFO, along with additional sites incorporated with permission from partner organizations. A centralized and accessibl...</description>
      <pubDate>Wed, 20 May 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Canada Gazette Part I: Notice of Intent — Consultation on potential amendments to the Industrial Hemp Regulations</title>
      <link>https://gazette.gc.ca/rp-pr/p1/2026/2026-05-16/html/notice-avis-eng.html#ne4</link>
      <guid isPermaLink="false">ad31f7c566852327e8b59a16e0dabcc5958ef9f11cc584649b7f105d6040caa0</guid>
      <description>Canada Gazette notice. Organization: Health, Dept. of. Authority: Cannabis Act.</description>
      <pubDate>Sat, 16 May 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Canada Gazette Part I: Publication of summary of the assessment of 10 substances in the Ketones Group specified on the Domestic Substances List and of Ministerial Statements (section 77 of the Canadian Environmental Protection Act, 1999)</title>
      <link>https://gazette.gc.ca/rp-pr/p1/2026/2026-05-16/html/notice-avis-eng.html#ne2</link>
      <guid isPermaLink="false">dac69d537092e201db997872ded16c09978d9a224fb8c99a8b3d034c2cd8c861</guid>
      <description>Canada Gazette notice. Organization: Environment, Dept. of the, and Dept. of Health. Authority: Canadian Environmental Protection Act, 1999.</description>
      <pubDate>Sat, 16 May 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Draft Federal Environmental Quality Guidelines for rare earth elements</title>
      <link>https://gazette.gc.ca/rp-pr/p1/2026/2026-05-16/html/notice-avis-eng.html#ne1</link>
      <guid isPermaLink="false">63c1e64a6d13a53430b894a01dfa63ea1c23904ee385857fb298dcc3ed539689</guid>
      <description>To seek comments on the Draft Federal Environmental Quality Guidelines for rare earth elements, published in the Canada Gazette, Part 1, Volume 160, Number 20 on May 16, 2026 Status: open. Consultation period: 2026-05-16 to 2026-07-15.</description>
      <pubDate>Sat, 16 May 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Risk Management Approach for the Ketones Group</title>
      <link>https://gazette.gc.ca/rp-pr/p1/2026/2026-05-16/html/notice-avis-eng.html#ne2</link>
      <guid isPermaLink="false">80ba36f8f4dc0900e8a2585971461751dff9fb4633e2b00b6672a8a9952d3e10</guid>
      <description>To seek comments on the Risk Management Approach for the Ketones Group, published in the Canada Gazette, Part 1, Volume 160, Number 20 on May 16, 2026 Status: open. Consultation period: 2026-05-16 to 2026-07-15.</description>
      <pubDate>Sat, 16 May 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Proposal to modify the List of Permitted Food Colours (Jagua (genipin-glycine) blue)</title>
      <link>https://www.canada.ca/en/health-canada/services/food-nutrition/legislation-guidelines/acts-regulations/notices-proposal-notices-modification/list-permitted-food-colours-jagua-genipin-glycine-blue.html</link>
      <guid isPermaLink="false">463034db2933375cec17b55b67932cacd89ddfa3ea853151b4bed4eb52f8ba8e</guid>
      <description>Jagua (genipin-glycine) blue is not currently authorized for use as a food additive in foods sold in Canada. As a result of the review of a food additive submission, Health Canada is proposing to authorize the use of jagua (genipin-glycine) blue as a food colour as shown in Table 1. Status: open. Consultation period: 2026-05-14 to 2026-07-28.</description>
      <pubDate>Thu, 14 May 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Consultation: Proposed change to the veterinary omeprazole listing on the Prescription Drug List (PDL)</title>
      <link>https://www.canada.ca/en/health-canada/programs/consultation-proposed-change-veterinary-omeprazole-listing-prescription-drug-list.html</link>
      <guid isPermaLink="false">ca0244a8728db6fae65b6dbff047cd99824ac48ba6429224e6dfecfd6f032e19</guid>
      <description>Health Canada is consulting Canadians on the proposal to allow certain veterinary drugs that contain omeprazole to be sold without a prescription. This consultation provides an opportunity to comment on a proposed change to the “omeprazole or its salts” listing on the veterinary use part of the Prescription Drug List (PDL). The proposal applies only to the veterinary listing. Status: open. Consultation period: 2026-05-13 to 2026-07-27.</description>
      <pubDate>Wed, 13 May 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Hamilton's Community Safety and Well-Being Data</title>
      <link>https://open.hamilton.ca/home/item.html?id=24639e4de3894045805d8b1d467d3726</link>
      <guid isPermaLink="false">b896bd4e69e6309740f73ae507d226b1fe0fe6f6de3192c3dd0312f0da8eb9da</guid>
      <description>Key indicators related to community safety and well-being across Hamilton, organized according to the City’s 2025–2029 Community Safety and Well-Being (CSWB) Plan focus areas.</description>
      <pubDate>Tue, 05 May 2026 17:30:38 +0000</pubDate>
    </item>
    <item>
      <title>Consultation on the proposed phased implementation of the incorporated by reference list for the Ministerial Reliance Order</title>
      <link>https://www.canada.ca/en/health-canada/programs/consultation-proposed-phased-implementation-incorporated-by-reference-list-ministerial-reliance-order.html</link>
      <guid isPermaLink="false">15ec7c23dcfe11fab15453ce3083447df06f019d303a616ec5205a74e1f2f270</guid>
      <description>Health Canada is seeking feedback on the proposed phased implementation of the incorporated by reference (IbR) list under the proposed Ministerial Reliance Order (Order). This includes feedback on the development and updating of the IbR list, as well as the high-level categories proposed for Phase 1. Read the proposed phased implementation of the incorporated by reference list for the Ministerial Reliance Order notice to learn more about the proposed Order and how the IbR list would be develo...</description>
      <pubDate>Tue, 05 May 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Heat Related Illness Reporting</title>
      <link>https://open.hamilton.ca/home/item.html?id=c4c3dd3a7f4b4c5eb63bd2f839b8005a</link>
      <guid isPermaLink="false">4c5470d1e366236653ff74ea7f6f9cda8119a24f7a4ba138161d13efa9a6c5cf</guid>
      <description>Daily counts of paramedic calls related to heat related illness in Hamilton.</description>
      <pubDate>Thu, 30 Apr 2026 16:14:24 +0000</pubDate>
    </item>
    <item>
      <title>Consultation on GATTEN Fungicide, containing flutianil, Proposed Registration Decision PRD2026-08</title>
      <link>https://www.canada.ca/en/health-canada/services/consumer-product-safety/pesticides-pest-management/public/consultations/proposed-registration-decisions/2026/gattent-fungicide-containing-flutianil.html</link>
      <guid isPermaLink="false">7ca5bf265f542ce4e4a34d08346301137236b28bb147eecb46ee0cbd498d0d7b</guid>
      <description>Health Canada, is proposing registration for the sale and use of GATTEN Fungicide, containing the technical grade active ingredient flutianil, to control powdery mildew species on greenhouse vegetables (pepper, eggplant, cucumber and tomato) and greenhouse ornamentals. An evaluation of available scientific information found that, under the approved conditions of use, the health and environmental risks and the value of the pest control product is acceptable. Status: open. Consultation period:...</description>
      <pubDate>Thu, 30 Apr 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Canada Emergency Wage Subsidy (CEWS) Registry</title>
      <link>https://open.canada.ca/data/dataset/31de6c65-5d87-4982-9f9a-c7af55973c27</link>
      <guid isPermaLink="false">cdb090b2f8c7a2f9811dcc959a9634ad6987467954d21f780b52c60205cdb402</guid>
      <description>CEWS was a wage subsidy program for employers in Canada who were affected by the COVID-19 pandemic between March 15, 2020, and October 23, 2021. The CEWS registry lists employers who have received the CEWS. This registry is no longer being updated as the final claim period for the benefit ended on October 23, 2021, and the period to submit applications for CEWS ended April 21, 2022. **Included in the dataset** This dataset includes the legal name and operating/trade name of a corporation or a...</description>
      <pubDate>Wed, 29 Apr 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Consultation on AGRI-MEK SC, containing abamectin, Proposed Registration Decision PRD2026-05</title>
      <link>https://www.canada.ca/en/health-canada/services/consumer-product-safety/pesticides-pest-management/public/consultations/proposed-registration-decisions/2026/agri-mek-sc-containing-abamectin.html</link>
      <guid isPermaLink="false">8374ffb7207775363d9480aac75de59407cf52af8d40bce9d15ac45cedb31d9b</guid>
      <description>Health Canada is proposing registration for the sale and use of AGRI-MEK SC, containing the technical grade active ingredient abamectin, to control stem and bulb nematodes (Ditylenchus dipsaci) on garlic bulbs. An evaluation of available scientific information found that, under the approved conditions of use, the health and environmental risks and the value of the pest control product is acceptable. Status: open. Consultation period: 2026-04-28 to 2026-06-12.</description>
      <pubDate>Tue, 28 Apr 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Risk Management Approach for the Alkyl Halides Group</title>
      <link>https://gazette.gc.ca/rp-pr/p1/2026/2026-04-25/html/notice-avis-eng.html#na2</link>
      <guid isPermaLink="false">43b596d9d327c24f0a00fcc592ece9eb3cb6c892a78018efcd50b34f0d57f044</guid>
      <description>To seek comments on the Risk Management Approach for the Alkyl Halides Group, published in the Canada Gazette, Part 1, Volume 160, Number 17 on April 25, 2026 Status: open. Consultation period: 2026-04-25 to 2026-06-24.</description>
      <pubDate>Sat, 25 Apr 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>LEGISinfo bill S-230: National Strategy for Soil Health Act</title>
      <link>https://www.parl.ca/legisinfo/en/bill/45-1/s-230</link>
      <guid isPermaLink="false">e5f3dfed5a998eca3aa54cfe95e284e0c8cf2cd3dff07f4d673412aa7b31dbd2</guid>
      <description>Senate Public Bill. Status: At second reading in the House of Commons. Latest activity: Placed in the Order of Precedence on April 22, 2026 (House of Commons). Sponsor: Sen. Robert Black.</description>
      <pubDate>Wed, 22 Apr 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Drug product: AG-AMOXICILLIN (DIN 02477726)</title>
      <link>https://health-products.canada.ca/dpd-bdpp/info?lang=eng&amp;code=96865</link>
      <guid isPermaLink="false">03aedb497f370cc6dc36bad3e8f28ba51b44e7f4d07f12f872c2303ba94ce072</guid>
      <description>Health Canada Drug Product Database record. Company: ANGITA PHARMA INC.. Class: Human. Active ingredient count: 1.</description>
      <pubDate>Mon, 20 Apr 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Consultation on AQUABAC II XT Biological Larvicide, containing Bacillus thuringiensis subsp. Israelensis serotype H-14, strain BMP-144, Proposed Registration Decision PRD2026-07</title>
      <link>https://www.canada.ca/en/health-canada/services/consumer-product-safety/pesticides-pest-management/public/consultations/proposed-registration-decisions/2026/aquabac-ii-xt-biological-larvicide-containing-bacillus-thuringiensis-subsp-israelensis-serotype-h-14-strain-bmp-144.html</link>
      <guid isPermaLink="false">14fe03995507e8d456afe90a9becc9f1d8f0afc3f751f8a2464ba74e82aa7101</guid>
      <description>Health Canada is proposing registration for the sale and use of AQUABAC II XT Biological Larvicide, containing Bacilllus thuringiensis subsp. israelensis serotype H-14, strain BMP-144, to control fungus gnats on greenhouse ornamentals (use-site category 6 – Greenhouse Non-Food). This evaluation was completed under the User Requested Minor Use Label Expansion program, which is a cooperative program between Agriculture and Agri-Food Canada and Health Canada and includes participation by sponsor...</description>
      <pubDate>Mon, 20 Apr 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>LEGISinfo bill S-201: National Framework on Sickle Cell Disease Act</title>
      <link>https://www.parl.ca/legisinfo/en/bill/45-1/s-201</link>
      <guid isPermaLink="false">6e51eaa08368b986fce6b067d345c612572d1b9e142ba551265de7c530bd52d8</guid>
      <description>Senate Public Bill. Status: At second reading in the House of Commons. Latest activity: Debate at second reading on April 17, 2026 (House of Commons). Sponsor: Sen. Marie-Françoise Mégie.</description>
      <pubDate>Fri, 17 Apr 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Consultation: Canadian Access, Watch, Reserve classification of antimicrobial drugs for human use</title>
      <link>https://www.canada.ca/en/health-canada/programs/consultation-canadian-access-watch-reserve-classification-antimicrobial-drugs-human-use.html</link>
      <guid isPermaLink="false">011159bbd22188785160a47a9b08d11e95bcd90900e8d7c3065d60c271d89cf8</guid>
      <description>Health Canada is seeking stakeholder feedback on the proposed Canadian Access, Watch, Reserve (CAN-AWaRe) classification of antimicrobial drugs for human use. We will consider all comments received before finalizing the CAN-AWaRe classification. Status: open. Consultation period: 2026-04-09 to 2026-06-08.</description>
      <pubDate>Thu, 09 Apr 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Drug product: AMOXICILLIN CAPSULES BP (DIN 02525348)</title>
      <link>https://health-products.canada.ca/dpd-bdpp/info?lang=eng&amp;code=101436</link>
      <guid isPermaLink="false">c6d6993cb5feec7de5f494fcc7aa2e07186d786fbf34388456cdfc141234cc00</guid>
      <description>Health Canada Drug Product Database record. Company: SANIS HEALTH INC. Class: Human. Active ingredient count: 1.</description>
      <pubDate>Wed, 08 Apr 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Drug product: AMOXICILLIN CAPSULES BP (DIN 02525356)</title>
      <link>https://health-products.canada.ca/dpd-bdpp/info?lang=eng&amp;code=101437</link>
      <guid isPermaLink="false">f9d7b096994bf3a0f99a09e3f630bdae2f0a6258b0271caf86436dca6367cf1c</guid>
      <description>Health Canada Drug Product Database record. Company: SANIS HEALTH INC. Class: Human. Active ingredient count: 1.</description>
      <pubDate>Wed, 08 Apr 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Senate committee report: Bill S-5, An Act respecting the interoperability of health information technology and to prohibit data blocking by health information technology vendors, with amendment and observations</title>
      <link>https://sencanada.ca/en/committees/SOCI/Report/155378/45-1</link>
      <guid isPermaLink="false">59557766641c18ce8db795ea2127a977bda37b66a5e6d4a92f2d0b8d2fb5e548</guid>
      <description>Seventh Report. Committee: The Standing Senate Committee on Social Affairs, Science and Technology. Report title: Bill S-5, An Act respecting the interoperability of health information technology and to prohibit data blocking by health information technology vendors, with amendment and observations. Date listed by the Senate: April 2026.</description>
      <pubDate>Wed, 01 Apr 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Consultation on famoxadone and its associated end-use product, Proposed Re-evaluation Decision PRVD2026-02</title>
      <link>https://www.canada.ca/en/health-canada/services/consumer-product-safety/pesticides-pest-management/public/consultations/proposed-re-evaluation-decisions/2026/famoxadone.html</link>
      <guid isPermaLink="false">f56042c840c55ca7779377aa01909381279429f31b54c01323dc0dd665c821d0</guid>
      <description>Health Canada is consulting Canadians on the proposal to continue registration of famoxadone and its associated end-use product registered for sale and use in Canada, with proposed updates to standard label statements. Status: open. Consultation period: 2026-03-31 to 2026-06-29.</description>
      <pubDate>Tue, 31 Mar 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>House committee report: Report 3 - Bill C-234, An Act respecting the establishment and award of a Living Donor Recognition Medal</title>
      <link>https://www.ourcommons.ca/DocumentViewer/en/45-1/HESA/report-3/</link>
      <guid isPermaLink="false">b9ae180952bfacaf32a706b31b25bf39d61f75e08f07ebf4ac70ae0518d3cab0</guid>
      <description>Report 3 presented to the House. Committee: HESA - Standing Committee on Health. Report title: Report 3 - Bill C-234, An Act respecting the establishment and award of a Living Donor Recognition Medal. Date listed by the House of Commons: Wednesday, March 25, 2026.</description>
      <pubDate>Wed, 25 Mar 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>House committee report: Report 4 - Supplementary Estimates (C), 2025-26: Vote 5c under Canadian Institutes of Health Research, Vote 10c under Department of Health, Votes 1c and 10c under Public Health Agency of Canada</title>
      <link>https://www.ourcommons.ca/DocumentViewer/en/45-1/HESA/report-4/</link>
      <guid isPermaLink="false">221fa071bc827eda34196e95a6c084df20bd298d41858179970f10817b5912f2</guid>
      <description>Report 4 presented to the House. Committee: HESA - Standing Committee on Health. Report title: Report 4 - Supplementary Estimates (C), 2025-26: Vote 5c under Canadian Institutes of Health Research, Vote 10c under Department of Health, Votes 1c and 10c under Public Health Agency of Canada. Date listed by the House of Commons: Wednesday, March 25, 2026.</description>
      <pubDate>Wed, 25 Mar 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Senate committee transcript: AGFO - Bill S-230, An Act respecting the development of a national strategy for soil health protection, conservation and enhancement; Examine and report on the role of the agriculture and agri-food sector with regard to food security in Canada</title>
      <link>https://sencanada.ca/en/content/sen/committee/451/agfo/23ev-57547-e</link>
      <guid isPermaLink="false">0ca8da4bc52f2b5e0b5592f55d13498d905440a8965180b51c8698fe06b8ee08</guid>
      <description>Senate committee transcript. Committee: AGFO - Agriculture and Forestry. Meeting date: Mar 10, 2026 07:08 p.m. ET.</description>
      <pubDate>Tue, 10 Mar 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Medical device licence: GLUCOCHECK MULTI-PATIENT BLOOD GLUCOSE MONITORING SYSTEM (115004)</title>
      <link>https://health-products.canada.ca/mdall-limh/information?lang=eng&amp;licenceId=115004&amp;type=active</link>
      <guid isPermaLink="false">a894a0b5c535faf55edea9e437df76b33eea67cc520a1d4c5ec04f8145b62a06</guid>
      <description>Health Canada Medical Devices Active Licence Listing record. Licence status: issued-active. Risk class: 3. Licence type: System. Company ID: 105068.</description>
      <pubDate>Mon, 02 Mar 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Men and Boys' Health Strategy</title>
      <link>https://www.canada.ca/en/health-canada/services/healthy-living/improving-health-men-canada.html</link>
      <guid isPermaLink="false">2948003ae237cb8884ee85ad07d2933345ac7ccee6847c90b003a07091f9f7ca</guid>
      <description>The Government of Canada is inviting Canadians (over the age of 16) to help shape the country's first Men and Boys' Health Strategy by completing a short online questionnaire. Status: open. Consultation period: 2026-03-02 to 2026-06-01.</description>
      <pubDate>Mon, 02 Mar 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Senate committee report: Bill S-230, An Act respecting the development of a national strategy for soil health protection, conservation and enhancement, with amendment</title>
      <link>https://sencanada.ca/en/committees/AGFO/Report/152270/45-1</link>
      <guid isPermaLink="false">352cee1fde9550838ccc869441d1a5318e31caf6e9f361dfa87fe4a12359b545</guid>
      <description>Third Report. Committee: The Standing Senate Committee on Agriculture and Forestry. Report title: Bill S-230, An Act respecting the development of a national strategy for soil health protection, conservation and enhancement, with amendment. Date listed by the Senate: March 2026.</description>
      <pubDate>Sun, 01 Mar 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Library of Parliament Legislative Summary: Legislative Summary of Bill C-16: An Act to amend certain Acts in relation to criminal and correctional matters (child protection, gender-based violence, delays and other measures)</title>
      <link>https://lop.parl.ca/sites/PublicWebsite/default/en_CA/ResearchPublications/LegislativeSummaries/451C16E</link>
      <guid isPermaLink="false">174ef6201bccfe1e28642c35607b40427439e19425b850d6c2ea0521ad2c7c5f</guid>
      <description>Legislative Summary from the Library of Parliament. Authors: Alexsandra Ferland, Dana Phillips, Isabelle Chénier, Michaela Keenan-Pelletier. Subjects: Law, justice and rights, Health and safety.</description>
      <pubDate>Sat, 28 Feb 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Senate committee transcript: AGFO - Bill S-230, An Act respecting the development of a national strategy for soil health protection, conservation and enhancement</title>
      <link>https://sencanada.ca/en/content/sen/committee/451/agfo/22ev-57532-e</link>
      <guid isPermaLink="false">c0bac8d721d2add937cefe6b1ccf2c16ad1e9afe79aecc544ceda12b99c73c3a</guid>
      <description>Senate committee transcript. Committee: AGFO - Agriculture and Forestry. Meeting date: Feb 26, 2026 08:01 a.m. ET.</description>
      <pubDate>Thu, 26 Feb 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Senate committee transcript: AGFO - Bill S-230, An Act respecting the development of a national strategy for soil health protection, conservation and enhancement</title>
      <link>https://sencanada.ca/en/content/sen/committee/451/agfo/21ev-57521-e</link>
      <guid isPermaLink="false">33a3c51ca42f7611f9378b0f2c2606339961619deaddfb618671c0e5202e6cb4</guid>
      <description>Senate committee transcript. Committee: AGFO - Agriculture and Forestry. Meeting date: Feb 24, 2026 07:31 p.m. ET.</description>
      <pubDate>Tue, 24 Feb 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>PBO Report: Projecting the Cost of the Interim Federal Health Program</title>
      <link>https://www.pbo-dpb.ca/en/publications/RP-2526-023-C--projecting-cost-interim-federal-health-program--prevision-cout-programme-federal-sante-interimaire</link>
      <guid isPermaLink="false">02eb54e99c107ccc77deb34b732d1372c4751a08d2890b4eb0c6cf9f966b2f27</guid>
      <description>Report from the Office of the Parliamentary Budget Officer. In response to a request by the Standing Committee on Health, this report projects the fiscal cost of the Interim Federal Health Program and details some of the key cost drivers.</description>
      <pubDate>Thu, 12 Feb 2026 14:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Library of Parliament Legislative Summary: Legislative Summary of Bill S-5: An Act respecting the interoperability of health information technology and to prohibit data blocking by health information technology vendors</title>
      <link>https://lop.parl.ca/sites/PublicWebsite/default/en_CA/ResearchPublications/LegislativeSummaries/451S5E</link>
      <guid isPermaLink="false">e809fcb89f77276b4003dfa9a6fa0f1cbdad997014991ed2793784269b67bc80</guid>
      <description>Legislative Summary from the Library of Parliament. Authors: Dana Fan, Joey Arseneault-Watters, Tu-Quynh Trinh. Subjects: Information and communications, Law, justice and rights, Business, industry and trade, Health and safety.</description>
      <pubDate>Thu, 12 Feb 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Drug product: AG-AMOXICILLIN (DIN 02537451)</title>
      <link>https://health-products.canada.ca/dpd-bdpp/info?lang=eng&amp;code=102617</link>
      <guid isPermaLink="false">f338febde733a0b74b37bedfc0b50b5de2ff93f65aca62fd8d26390289da3f54</guid>
      <description>Health Canada Drug Product Database record. Company: ANGITA PHARMA INC.. Class: Human. Active ingredient count: 1.</description>
      <pubDate>Fri, 06 Feb 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Senate committee transcript: AGFO - Bill S-230, An Act respecting the development of a national strategy for soil health protection, conservation and enhancement</title>
      <link>https://sencanada.ca/en/content/sen/committee/451/agfo/19ev-57471-e</link>
      <guid isPermaLink="false">f44d92c96725a6b103b0949144d904f517ab6fea1800d4f7581784f6e5a41951</guid>
      <description>Senate committee transcript. Committee: AGFO - Agriculture and Forestry. Meeting date: Feb 05, 2026 08:00 a.m. ET.</description>
      <pubDate>Thu, 05 Feb 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Senate committee transcript: AGFO - Bill S-230, An Act respecting the development of a national strategy for soil health protection, conservation and enhancement</title>
      <link>https://sencanada.ca/en/content/sen/committee/451/agfo/18ev-57457-e</link>
      <guid isPermaLink="false">7994c11e0030444c86ee7a9bd51f91241e07af66ca167e4c8bae361f3245bf16</guid>
      <description>Senate committee transcript. Committee: AGFO - Agriculture and Forestry. Meeting date: Feb 03, 2026 06:31 p.m. ET.</description>
      <pubDate>Tue, 03 Feb 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Senate committee report: Breaking Down Language Barriers in Health Care: For Equitable, Safe and Quality Health Care and Health Services</title>
      <link>https://sencanada.ca/en/committees/OLLO/Report/148898/45-1</link>
      <guid isPermaLink="false">85e61071f954ca8df4e884d4dbc1a1d493a0daa14a7e6426c810177ca61fb7ec</guid>
      <description>First Report. Committee: The Standing Senate Committee on Official Languages. Report title: Breaking Down Language Barriers in Health Care: For Equitable, Safe and Quality Health Care and Health Services. Date listed by the Senate: February 2026.</description>
      <pubDate>Sun, 01 Feb 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Drug product: JAMP-AMOXICILLIN (DIN 02433060)</title>
      <link>https://health-products.canada.ca/dpd-bdpp/info?lang=eng&amp;code=91747</link>
      <guid isPermaLink="false">4ba026b850cd3bb5604e03ab032d62c5874683f0ccc574170029355a69883e76</guid>
      <description>Health Canada Drug Product Database record. Company: JAMP PHARMA CORPORATION. Class: Human. Active ingredient count: 1.</description>
      <pubDate>Fri, 23 Jan 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Drug product: JAMP-AMOXICILLIN (DIN 02433079)</title>
      <link>https://health-products.canada.ca/dpd-bdpp/info?lang=eng&amp;code=91748</link>
      <guid isPermaLink="false">d020a6ff024384d9c20c3972a337af6878a7351c1a642d327022c81ca84873d1</guid>
      <description>Health Canada Drug Product Database record. Company: JAMP PHARMA CORPORATION. Class: Human. Active ingredient count: 1.</description>
      <pubDate>Fri, 23 Jan 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Evaluation and Audit of the Global Arctic Leadership Initiative, 2020-21 to 2023-24</title>
      <link>https://open.canada.ca/data/dataset/5d7c692e-69e4-4438-8a59-3ef067d370c8</link>
      <guid isPermaLink="false">ef84c0bde63597b821ae1b2977bb2b7df470df880cb80a231d51fa7cd9929f57</guid>
      <description>Since the 1990s, Global Affairs Canada (GAC) has supported the international dimension of Canada’s Arctic priorities through a series of funds. In 2020, these funds were expanded and became the Global Arctic Leadership Initiative (GALI), designed to bolster Canadian leadership and enhance participation of Arctic and northern Canadians in international forums. The joint evaluation and audit of the Global Arctic Leadership Initiative (2020-21 to 2023-24) examined strengths, gaps and opportuniti...</description>
      <pubDate>Thu, 22 Jan 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Consultations on the Next Agricultural Policy Framework</title>
      <link>https://agriculture.canada.ca/en/department/transparency/public-opinion-research-consultations/share-ideas-next-agricultural-policy-framework-0</link>
      <guid isPermaLink="false">89f9cb9a0cdba0f0d4ce0a77f07c203eb300e1edb10cb3c1737d3681122d657a</guid>
      <description>To consult with Canadians, including stakeholders such as producers, processors, Indigenous communities, women in agriculture, youth, environmental organizations, and small and emerging sectors to develop the successor to the Sustainable Canadian Agricultural Partnership. Status: open. Consultation period: 2026-01-20 to 2026-06-30.</description>
      <pubDate>Tue, 20 Jan 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Library of Parliament Research Publication: Wrongful Convictions in Canada</title>
      <link>https://lop.parl.ca/sites/PublicWebsite/default/en_CA/ResearchPublications/202077E</link>
      <guid isPermaLink="false">2601680781e0c4efbf683ca4397b9e78e2c5fc067ca44c3f468f97ba7bf614e0</guid>
      <description>Research Publication from the Library of Parliament. Authors: Robert Mason. Subjects: Law, justice and rights, Health and safety.</description>
      <pubDate>Wed, 14 Jan 2026 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Drug product: AMOXICILLIN (DIN 02401509)</title>
      <link>https://health-products.canada.ca/dpd-bdpp/info?lang=eng&amp;code=88640</link>
      <guid isPermaLink="false">3cd5e9a496f01f77e5677d49e52c5781bb62f00e585d1f4cae63cac87a7bec18</guid>
      <description>Health Canada Drug Product Database record. Company: SIVEM PHARMACEUTICALS ULC. Class: Human. Active ingredient count: 1.</description>
      <pubDate>Thu, 18 Dec 2025 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>PBO Legislative Costing Note: An Act to amend the Canada Health Act (mental, addictions and substance use health services)</title>
      <link>https://www.pbo-dpb.ca/en/publications/LEG-2526-006-M--an-act-amend-canada-health-act-mental-addictions-substance-use-health-services--loi-modifiant-loi-canadienne-sante-services-sante-matiere-sante-mentale-dependances-consommation-sub</link>
      <guid isPermaLink="false">3aa55fee10e34855253e3633f48575773275fb568672523034d5b8e5a4535dce</guid>
      <description>Legislative Costing Note from the Office of the Parliamentary Budget Officer. Bill C-201 proposes to amend the Canada Health Act to add mental, addictions and substance use health services to the definition of “insured health services”. If implemented January 1, 2026, PBO estimates the net federal cost of Bill C-201 would be $24.4 billion over 2025-26 to 2029-30.</description>
      <pubDate>Tue, 16 Dec 2025 14:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Share your views and ideas: Review of the Environmental Emergency Regulations, 2019</title>
      <link>https://www.canada.ca/en/environment-climate-change/corporate/transparency/consultations/environmental-emergencies-regulations-consultation.html</link>
      <guid isPermaLink="false">ea6be26ded7daf56ebcd60b8e97111cc5d7bb057ff5f92c653f844910d084ff9</guid>
      <description>Since the publication of the E2 Regulations in 2019, some industry stakeholders have reported significant challenges around its implementation and effectiveness. Through this consultation, ECCC is engaging with a broader audience to help determine if these, or other challenges, such as regulatory burden, should be considered for regulatory amendments to improve the effectiveness of the E2 Regulations. Status: open. Consultation period: 2025-12-15 to 2026-02-13.</description>
      <pubDate>Mon, 15 Dec 2025 00:00:00 +0000</pubDate>
    </item>
    <item>
      <title>Retirement abroad: seeing the sunsets</title>
      <link>https://open.canada.ca/data/dataset/a01aba94-4ab6-4814-bd01-c446742d5c5d</link>
      <guid isPermaLink="false">116cc2e75d86f40690b98ff7d9a9382eb047604b567e92d4e1acd9cca1d6a637</guid>
      <description>Archived and Outdated Information: This publication is out of date and should be referenced for research or recordkeeping purposes only. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. You can request an alternate version of our publications by email at Accessibilite-accessibility@international.gc.ca or telephone at 1-800-267-8376. This booklet is meant to help retirees consider their choices and prepare for potential diff...</description>
      <pubDate>Mon, 08 Dec 2025 00:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
